Molecular and thermodynamic aspects of solubility advantage from solid dispersions

Molecular Pharmaceutics

Volumn 4, Issue 5, 2007, Pages 794-802

  Bansal, Shyam Sunder ^a   Kaushal, Aditya Mohan ^a   Bansal, Arvind Kumar ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Amorphous; Entropy; Etoricoxib; Interactions; Solid dispersions; Solubility; Solution thermodynamics; Valdecoxib

Indexed keywords

ETORICOXIB; POVIDONE; VALDECOXIB;

ARTICLE; DRUG SOLUBILITY; ENTHALPY; ENTROPY; HYDROGEN BOND; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; PRIORITY JOURNAL; THERMODYNAMICS;

ISOXAZOLES; MOLECULAR STRUCTURE; PYRIDINES; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONAMIDES; SULFONES; THERMODYNAMICS;

EID: 35548944559     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp7000796     Document Type: Article

References (30)

1. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 2001, 46, 3-26.
2. Kaushal, A. M.; Gupta, P.; Bansal, A. K. Amorphous drug delivery systems: molecular aspects, design and performance. Crit. Rev. Ther. Drug Carrier Syst. 2004, 21, 133-193.
3. Spong, B. R.; Price, C. P.; Jayasankar, A.; Matzger, A. J.; Hornedo, N. R. General principles of pharmaceutical solid polymorphism: a supramolecular perspective. Adv. Drug Delivery Rev. 2004, 56, 241-274.
4. Kakumanu, V. K.; Bansal, A. K. Enthalpy relaxation studies of celecoxib amorphous mixtures. Pharm. Res. 2002, 19, 1873-1878.
5. Leuner, C.; Dressman, J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50, 47-60.
6. Debendetti, P. G.; Stillinger, F. H. Supercooled liquids and the glass transition. Nature 2001, 410, 259-267.
7. Singhal, D.; Curatolo, W. Drug polymorphism and dosage form design: a practical perspective. Adv. Drug Delivery Rev. 2004, 56, 335-347.
8. Craig, D. Q. M. The mechanisms of drug release from solid dispersions in water soluble polymers. Int. J. Pharm. 2002, 231, 131-144.
9. Gupta, P.; Kakumanu, V. K.; Bansal, A. K. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 2004, 21, 1762-1769.
10. Simonelli, A. P.; Mehta, S. C.; Higuchi, W. I. Dissolution rates of high energy sulfathiazole-povidone co-precipitates II: characterization of form of drug controlling its dissolution rate via solubility studies. J. Pharm. Sci. 1976, 65, 355-361.
11. Shalaev, E. Y.; Zografi, G. How does residual water affect the solid state degradation of drugs in the amorphous state. J. Pharm. Sci. 1996, 85, 1137-1141.
12. Nair, R.; Gonen, S.; Hoag, S. W. Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine. Int. J. Pharm. 2002, 240, 11-22.
13. Karavas, E.; Ktistis, G.; Xenakis, A.; Georgarakis, E. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur J. Pharm. Biopharm. 2006, 63, 103-114.
14. Johari, G. P.; Hallbrucker, A.; Mayer, E. The glass-liquid transition of hyperquenched water. Nature 1987, 330, 552-553.
15. Vasanthavada, M.; Tong, W. T.; Joshi, Y.; Kislalioglu, M. S. Phase behavior of amorphous molecular dispersions I: determination of the degree and mechanism of solid solubility. Pharm. Res. 2004, 21, 1598-1606.
16. Hancock, B. C. Disordered drug delivery: destiny, dynamics and the Deborah number. J. Pharm. Pharmacol. 2002, 54, 737-746.
17. Ambike, A. A.; Mahadik, K. R.; Paradkar, A. Stability study of amorphous valdecoxib. Int. J. Pharm. 2004, 282, 151-162.
18. Sony, S. M. M.; Charles, P.; Ponnuswamya, M. N.; Yathirajan, H. S. Valdecoxib, a non-steroidal anti-inflammatory drug. Acta Crystallogr. 2005, E61, o108-o110.
19. Chauhan, B.; Shimpi, S.; Paradkar, A. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. AAPS PharmSciTech 2005, 6, E405-E412.
20. Gupta, P.; Bansal, A. K. Molecular interactions in celecoxib-PVP- meglumine amorphous system. J. Pharm. Pharmacol. 2005, 57, 303-310.
21. Corrigan, O. I. Retardation of polymeric carrier dissolution by dispersed drugs: factors influencing the dissolution of solid dispersions containing polyethylene glycols. Drug Dev. Ind. Pharm. 1986, 12, 1777-1793.
22. Saers, E. S.; Craig, D. Q. M. An investigation into the mechanisms of dissolution of alkyl p-aminobenzoates from polyethylene glycol solid dispersions. Int. J. Pharm. 1992, 83, 211-219.
23. Corrigan, O. I. Mechanisms of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm. 1985, 11, 697-724.
24. Dubois, J. L.; Ford, J. L. Similarities in the release rates of different drugs from polyethylene glycol 6000 solid dispersions. J. Pharm. Pharmacol. 1985, 37, 494-496.
25. Corrigan, O. I.; Stanley, C. T. Mechanism of drug dissolution rate enhancements from b cyclodextrin drug systems. J. Pharm. Pharmacol. 1982, 34, 621-626.
26. Yalkowski, S. H.; Flynn, G. L.; Amidon, G. L. Solubility of non electrolytes in polar solvents. J. Pharm. Sci. 1972, 61, 983-984.
27. Hodge, I. M. Adam-Gibbs formulation of enthalpy relaxation near the glass transition. J. Res. Natl. Inst. Stand. Technol. 1997, 102, 195-205.
28. Paruta, A. N. Thermodynamics of aqueous solutions of alkyl p-aminobenzoate. Drug Dev. Ind. Pharm. 1984, 10, 453-465.
29. Liu, C.; Liu, C.; Desai, K. G. H. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Dev. Ind. Pharm. 2005, 1, 1-10.
30. Gupta, P.; Chawla, G.; Bansal, A. K. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility. Mol. Pharmaceutics 2004, 1, 406-413.